A
Atara Biotherapeutics
Developing t-cell therapies
About Atara Biotherapeutics
Atara Biotherapeutics is a pioneering company in the field of off-the-shelf, allogeneic T cell immunotherapy. Founded in 2012, Atara focuses on developing novel treatments for patients suffering from cancer, autoimmune, and viral diseases. The company operates primarily in the biopharmaceutical sector, targeting a niche market that includes healthcare providers, research institutions, and patients in need of advanced immunotherapy solutions.
Atara's business model revolves around the research, development, and commercialization of its proprietary T cell therapies. These therapies are designed to be readily available 'off-the-shelf,' meaning they do not require customization for each individual patient, which significantly reduces treatment time and costs. The company generates revenue through the sale of its therapies, partnerships with other biopharmaceutical companies, and potential future licensing agreements.
Atara's innovative approach and commitment to advancing medical science have positioned it as a leader in the immunotherapy space. The company continues to present its advancements and key milestones at major healthcare conferences, reflecting its ongoing dedication to improving patient outcomes.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2014
- Outcome tier
- Thoroughbred$100M+ revenue
News
Open roles
Atara Biotherapeutics in the Thousand Oaks ecosystem
The Atara Biotherapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Domain Associates
Kleiner Perkins
Series B and later4 investors entered at this stage
4BIO Capital
EcoR1 Capital
Redmile Group
Adiumentum Capital Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
10 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Atara Biotherapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Atara Biotherapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
